Prassede Salutari

GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia

Adriano Venditti, Alfonso Piciocchi, Anna Candoni et al. · Blood · 2019 · 208 citations · Full text

Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial

Esther Natalie Olíva, Caterina Alati, Valeria Santini et al. · The Lancet Haematology · 2017 · 159 citations · Full text

Eltrombopag Versus Placebo, Thrombosis, Thrombopoiesis +7

Evaluation of the Practice of Antifungal Prophylaxis Use in Patients With Newly Diagnosed Acute Myeloid Leukemia: Results From the SEIFEM 2010-B Registry

Livio Pagano, Morena Caira, Anna Candoni et al. · Clinical Infectious Diseases · 2012 · 83 citations · Full text

Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study)

Morena Caira, Anna Candoni, Luisa Verga et al. · Haematologica · 2015 · 78 citations · Full text

Results of a Multicenter, Controlled, Randomized Clinical Trial Evaluating the Combination of Piperacillin/Tazobactam and Tigecycline in High-Risk Hematologic Patients With Cancer With Febrile Neutropenia

Giampaolo Bucaneve, Alessandra Micozzi, Marco Picardi et al. · Journal of Clinical Oncology · 2014 · 69 citations · Full text